Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0406810 (
NAME
)
13,345
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hypertensive intracerebral hemorrhage (ICH) is a devastating cerebrovascular disease with no effective treatment.
Lysyl hydroxylase 3
(
LH3
) is essential for collagen IV intermolecular crosslinking and stabilization. Deficiency in
LH3
affects the assembly and secretion of collagen IV and basement membrane (BM) integrity of vessels. Here, we investigated whether
LH3
has significant implications for disease progression and therapeutic intervention. Spontaneous hypertensive ICH of mice was induced by angiotensin II and L-
NAME
treatment. The adeno-associated virus was delivered into brain by stereotactic injection to knockdown or overexpress
LH3
. We found
LH3
levels were reduced in human patients with ICH and gradually decreased in mice before ICH.
LH3
knockdown increased the incidence of hypertensive ICH in mice. The incidence, number, and size of ICHs in mice were markedly reduced by
LH3
overexpression. RNA-seq revealed that
LH3
overexpression significantly reversed the profound alterations in gene transcriptional profiles of cerebral vessels.
LH3
overexpression was sufficient to enhance BM integrity, inhibit matrix metalloproteinase activity, attenuate microglial activation and leukocyte infiltration, and reduce VSMC apoptosis before ICH. These results indicate that
LH3
overexpression attenuates susceptibility to hypertensive ICH. We emphasize that
LH3
modulation may serve as a viable approach for future investigations of ICH prevention.
...
PMID:Overexpression of LH3 reduces the incidence of hypertensive intracerebral hemorrhage in mice. 3051 6